This compound is a pharmaceutical intermediate used in the manufacturing of active pharmaceutical ingredients. It features an ester group and two ether linkages, contributing to its moderate lipophilicity and single hydrogen-bond donor.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 87129-32-6
Ethyl 2-(4-hydroxyphenoxy)propionate
Pharmaceutical intermediate for herbicide synthesis
(4-Chloro-3-cyanophenyl)boronic acid
Pharmaceutical intermediate for synthesis
3-((2S,5S)-5-((3R,5R)-5-Methyl-3-((methylsulfonyl)oxy)-6-(((trifluoromethyl)sulfonyl)oxy)hept-6-en-1-yl)-4-methylenetetrahydrofuran-2-yl)propyl pivalate
pharmaceutical intermediate
(1R,3S,5R,6R,7S,11R,14S,15S,16S,17R,18S,19S,20Z,22R,25S,28S,31S,33R)-5-[(2S)-2,3-bis[[tert-butyl(dimethyl)silyl]oxy]propyl]-16,17,19-tris[[tert-butyl(dimethyl)silyl]oxy]-22-hydroxy-6-methoxy-33-methyl-27,34-dimethylidene-4,35,36,37,38-pentaoxahexacyclo[29.3.1.111,15.114,18.125,28.03,7]octatriacont-20-en-9-one
pharmaceutical intermediate for complex polyether synthesis
1-Cinnamylpiperazine
Pharmaceutical intermediate for flunarizine
butyl (2R)-2-(4-hydroxyphenoxy)propanoate
MPNXVFDGEQKYAY-SNVBAGLBSA-N
CCCCOC(=O)[C@@H](C)OC1=CC=C(C=C1)O
—